Funder: National Institutes of Health (NIH)

Due Dates: February 25, 2026 (estimated, forecasted)

Funding Amounts: Not specified; award ceiling and floor not listed; duration and total funding to be announced in future NOFO.

Summary: Supports implementation of investigator-initiated, milestone-driven, high-risk clinical trials (including mechanistic studies) in allergy and infectious diseases.

Key Information: Forecasted opportunity—details subject to change; check program page for updates.